Development and validation of a reversed-phase HPLC method for determination of nitrendipine in rat plasma: Application to pharmacokinetic studies

Biomedical Chromatography

Volumn 21, Issue 4, 2007, Pages 363-368

  Venishetty, Vinay Kumar ^a,b   Durairaj, Chandrasekar ^a   Sistla, Ramakrishna ^a   Yamsani, Madhusudhan Rao ^b   Diwan, Prakash V ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b KAKATIYA UNIVERSITY   (India)

Author keywords

Lower of quantification; Nitrendipine; Pharmacokinetics; Rat plasma; Reversed phase HPLC; Solid lipid nanoparticles

Indexed keywords

BODY FLUIDS; DICHLOROMETHANE; NANOPARTICLES; PHARMACOKINETICS; RATS; SODIUM HYDROXIDE;

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID NANOPARTICLES; LOW OF QUANTIFICATION; NITRENDIPINE; PHARMACOKINETIC STUDIES; RAT PLASMA; REVERSED-PHASE HIGH PERFORMANCE; REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; SIMPLE METHOD; SOLID LIPID NANOPARTICLE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DICHLOROMETHANE; FELODIPINE; NITRENDIPINE; SODIUM HYDROXIDE; SOLID LIPID NANOPARTICLE;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STRUCTURE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

RATTUS;

EID: 34147178274     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.761     Document Type: Article

References (9)

1. Baranda AB, Etxebarria N, Jimenez RM and Alonso RM. Development of a liquid-liquid extraction procedure for five 1,4-dihydropyridines calcium channel antagonists from human plasma using experimental design. Talanta 2005; 67: 933.
2. Beck O and Ryman T. Quantification of nitrendipine in plasma by a capillary column gas chromatographic-mass spectrometric method, Journal of Chromatography 1985; 337: 402.
3. Fischer C, Heuer B, Heuck K and Eichelbaum M. Quantification of nitrendipine by stable isotope dilution and electron-capture negative ion chemical ionization, Biomedical and Environmental Mass Spectrometry 1986; 13: 645.
4. Heinig K and Bucheli F. Application of column-switching liquid chromatography-tandem mass spectrometry for the determination of pharmaceutical compounds in tissue samples, Journal of Chromatography B 2002; 769: 9.
5. Janis RA, Krol GJ and Noe AJ. Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum, Pan M. Journal of Clinical Pharmacology 1983; 23: 266.
6. Oh S-Y, Kim K-Y, Kim Y-G and Kim H-G. High-performance liquid chromatographic analysis of nitrendipine in human plasma using ultraviolet detection and single-step solid-phase sample preparation. Journal of Pharmaceutical and Biomedical Analysis 2003; 32: 387.
7. Santiago TM and Lopez LM. Nitrendipine: a new dihydropyridine calcium channel antagonist for the treatment of hypertension. Annals of Pharmacotherapy 1990; 4: 167.
8. Soons PA and Breimer DD. Gas chromatographic analysis of nitrendipine and its pyridine metabolite in human plasma, Journal of Chromatography: Biomedical Applications 1988; 428: 362.
9. Tipre DN and Vavia PR. Oxidative degradation study of nitrendipine using stability indicating HPLC, HPTLC and spectrophotometric method. Journal of Pharmaceutical and Biomedical Analysis 2001; 24: 705.